Β-amyloid, tau, neurodegeneration classification and eligibility for anti-amyloid treatment in a memory clinic population

HIGHLIGHTS

• who: Author(s et al. from the Medicine, University of Eastern Finland, Kuopio, Finland have published the research: u03b2-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population, in the Journal: (JOURNAL) of August/21,/2019
• what: The aim of this study was to apply ATN to a real-life memory clinic cohort and estimate potential eligibility for anti-Au03b2 disease modifying therapy. Standard protocol approvals, registrations, and patient consents GEDOC research database/biobank and this study have received ethical approval (Regional Ethical Review Board in Sweden; Dnr 2011 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.